1.Fernandez-Aviles F., San Roman J.A., Garcia-Frade J. et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 2004; 95: 742-8.2.Schachinger V., Assmus B., Britten M.B. et al. T ransplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 2004; 44: 1690-9.3.Meyer G.P., Wollert K.C. Lotz J. et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circ. 2006; 113: 1287-94.4.Strauer B.E., Brehm M., Zeus T. et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circ. 2002; 106: 1913-8.5.Janssens S., Dubois C., Bogaert J. et al. Autologous bone marrow-derived stemcell transfer in patients with ST-segment elevation myocardial infarction: doubleblind, randomised controlled trial. Lancet 2006; 367: 113-21.6.Penicka M., Widimsky P., Kobylka P. et al. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circ. 2005; 112: e63-e65.7.Perin E.C., Dohmann H.F.R., Borojevic R. et al. T ransendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circ. 2003; 107: 2294-302.